{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:36:47Z","timestamp":1783741007714,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.7759\/cureus.87222","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:42:52Z","timestamp":1751539372000},"source":"Crossref","is-referenced-by-count":1,"title":["Post-inflammatory Pigmentary Alteration (PIPA)-Like Disorder Following COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Larry M","family":"Bush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila M","family":"Fiallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria  T","family":"Vazquez-Pertejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15477","article-title":"COVID-19 and cutaneous manifestations: a review of the published literature","volume":"22","author":"Martora F","year":"2023","unstructured":"Martora F, Villani A, Fabbrocini G, Battista T. COVID-19 and cutaneous manifestations: a review of the published literature. J Cosmet Dermatol. 2023, 22:4-10. 10.1111\/jocd.15477","journal-title":"J Cosmet Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.89a.21126","article-title":"Common skin signs of COVID-19 in adults: an update","volume":"89","author":"Polly S","year":"2022","unstructured":"Polly S, Fernandez AP. Common skin signs of COVID-19 in adults: an update. Cleve Clin J Med. 2022, 89:161-7. 10.3949\/ccjm.89a.21126","journal-title":"Cleve Clin J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon DE","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, et al.. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021, 85:46-55. 10.1016\/j.jaad.2021.03.092","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20807","article-title":"COVID-19 vaccines and skin manifestations","volume":"186","author":"Bataille V","year":"2022","unstructured":"Bataille V, Puig S. COVID-19 vaccines and skin manifestations. Br J Dermatol. 2022, 186:15. 10.1111\/bjd.20807","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: review of world literature and own experience","volume":"36","author":"Gambichler T","year":"2022","unstructured":"Gambichler T, Boms S, Susok L, et al.. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022, 36:172-80. 10.1111\/jdv.17744","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225344","article-title":"Cutaneous adverse reactions associated with SARS-CoV-2 vaccines","volume":"10","author":"Bellinato F","year":"2021","unstructured":"Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with SARS-CoV-2 vaccines. J Clin Med. 2021, 10:5344. 10.3390\/jcm10225344","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14104","article-title":"Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination","volume":"49","author":"Larson V","year":"2022","unstructured":"Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA, Kim RH. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol. 2022, 49:34-41. 10.1111\/cup.14104","journal-title":"J Cutan Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2114","article-title":"Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines","volume":"157","author":"Robinson LB","year":"2021","unstructured":"Robinson LB, Fu X, Hashimoto D, Wickner P, Shenoy ES, Landman AB, Blumenthal KG. Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines. JAMA Dermatol. 2021, 157:1000-2. 10.1001\/jamadermatol.2021.2114","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07973-4","article-title":"COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review","volume":"23","author":"Agustin M","year":"2023","unstructured":"Agustin M, Trifitriana M, Danarti R. COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review. BMC Infect Dis. 2023, 23:7. 10.1186\/s12879-022-07973-4","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103340","article-title":"Insights into new-onset autoimmune diseases after COVID-19 vaccination","volume":"22","author":"Guo M","year":"2023","unstructured":"Guo M, Liu X, Chen X, Li Q. Insights into new-onset autoimmune diseases after COVID-19 vaccination. Autoimmun Rev. 2023, 22:103340. 10.1016\/j.autrev.2023.103340","journal-title":"Autoimmun Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01238-9","article-title":"Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis","volume":"28","author":"Shafiee A","year":"2023","unstructured":"Shafiee A, Amini MJ, Bahri RA, Jafarabady K, Salehi SA, Hajishah H, Mozhgani SH. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis. Eur J Med Res. 2023, 28:278. 10.1186\/s40001-023-01238-9","journal-title":"Eur J Med Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.036","article-title":"Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention","volume":"77","author":"Chaowattanapanit S","year":"2017","unstructured":"Chaowattanapanit S, Silpa-Archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol. 2017, 77:607-21. 10.1016\/j.jaad.2017.01.036","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031243","article-title":"Post-Inflammatory hypopigmentation: review of the etiology, clinical manifestations, and treatment options","volume":"12","author":"Rao M","year":"2023","unstructured":"Rao M, Young K, Jackson-Cowan L, Kourosh A, Theodosakis N. Post-Inflammatory hypopigmentation: review of the etiology, clinical manifestations, and treatment options. J Clin Med. 2023, 12:1243. 10.3390\/jcm12031243","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2165\/11536930-000000000-00000","article-title":"Postinflammatory hyperpigmentation: etiologic and therapeutic considerations","volume":"12","author":"Callender VD","year":"2011","unstructured":"Callender VD, St. Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011, 12:87-99. 10.2165\/11536930-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref15","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis EC","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010, 3:20-31.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref16","unstructured":"Post-inflammatory hyperpigmentation in patients with skin of color. (2016). Accessed. August 23: https:\/\/cdn-uat.mdedge.com\/files\/s3fs-public\/issues\/articles\/media_c9bcf47_CT097001009_e.PDF."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12849","article-title":"Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal","volume":"44","author":"Park JY","year":"2017","unstructured":"Park JY, Park JH, Kim SJ, Kwon JE, Kang HY, Lee ES, Kim YC. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017, 44:118-24. 10.1111\/cup.12849","journal-title":"J Cutan Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2009.08077","article-title":"Postinflammatory hyperpigmentation","volume":"13","author":"Taylor S","year":"2009","unstructured":"Taylor S, Grimes P, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009, 13:183-91. 10.2310\/7750.2009.08077","journal-title":"J Cutan Med Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2007.00211.x","article-title":"Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma","volume":"34","author":"Erbil H","year":"2007","unstructured":"Erbil H, Sezer E, Ta\u015ftan B, Arca E, Kurumlu Z. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol. 2007, 34:25-30. 10.1111\/j.1346-8138.2007.00211.x","journal-title":"J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/Pigmentinternational.Pigmentinternational_22_19","article-title":"Role of chemical peels in postinflammatory hyperpigmentation: a comprehensive review","volume":"6","author":"Dayal S","year":"2019","unstructured":"Dayal S, Sahu P, Sangal B, Sharma S. Role of chemical peels in postinflammatory hyperpigmentation: a comprehensive review. Pigment Int. 2019, 6:59-66. 10.4103\/Pigmentinternational.Pigmentinternational_22_19","journal-title":"Pigment Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/364803-post-inflammatory-pigmentary-alteration-pipa-like-disorder-following-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:42:53Z","timestamp":1751539373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/364803-post-inflammatory-pigmentary-alteration-pipa-like-disorder-following-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.87222","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}